Title of article
Ziprasidone in Treatment of Resistant Obsessive- Compulsive Disorder in a Female Adolescent
Author/Authors
Vahdani, A Department of Psychiatry - Iranian Hospital - Dubai, UAE , Haghighat, R College of Education and Psychology - Shiraz University , Mani, A Cognitive Neuroscience - Shiraz University of Medical Sciences, Shiraz
Pages
3
From page
461
To page
463
Abstract
While serotonin reuptake inhibitors (SSRIs) and behavioral therapy are the first-line agents in treatment of
obsessive-compulsive disorder (OCD), 40-60% of patients with the disorder do not respond to therapy. So other
neurotransmitters may play a role in OCD. In this regard, there has been particular interest in the dopaminergic
system, with various antipsychotic drugs having been used as adjunctive therapy for refractory OCD. This study
describes the efficacy of ziprasidone as adjuncts for treatment-resistant OCD in a young female adolescent.
Keywords
Adolescent , Female , Obsessive-compulsive disorder , Ziprasidone
Journal title
Astroparticle Physics
Serial Year
2009
Record number
2431239
Link To Document